ISCP International Symposium on Clinical Psychiatry

International event · São Paulo, Brazil

1st International Symposium on
Clinical Psychiatry

One evening with world-renowned psychiatrists on the most effective yet underused interventions in clinical practice: lithium, clozapine, ECT, diagnosis, and much more.

Nassir Ghaemi, Pedro do Prado Lima, Márcia Kauer-Sant'Anna e Elias Ajub
Nassir Ghaemi · Pedro do Prado Lima · Márcia Kauer-Sant'Anna · Elias Ajub
October 29, 2026 6–10 PM ET São Paulo, Brazil

Early-access pre-sale pricing

Presented by

The Psychiatry Letter + Instituto MedExperts + Sirius

Thursday, Oct 29, 2026

From 6 PM to 10 PM Eastern Time (7 PM to 11 PM Brasília time), during the week of Brazil's largest psychiatry congress.

International round table + book launch

An international scientific round table followed by a special book launch.

Why this symposium

Psychiatry's most effective interventions.
And its least prescribed.

In clinical practice, the most comfortable protocol is not always the most effective one. Treatments backed by decades of robust evidence remain underprescribed due to inherited fears, training myths, and practical barriers. In this evening, national and international experts show what the evidence really supports, how it changes diagnosis, and how to bring these interventions back into your practice.

Pedro do Prado Lima
Opening · Moderation

Highly effective and rarely prescribed

Dr. Pedro do Prado Lima opens the evening and moderates the panel

Lithium, clozapine and ECT: why psychiatry's three highest-impact interventions remain at the margins of daily practice.

On the table · Dr. Elias Ajub

ECT today

How to prescribe it and how to build a reference electroconvulsive therapy service.

  • The treatment with the highest response rates in psychiatry, surrounded by stigma the evidence does not support
  • Indication, referral, and what to tell the patient and family when proposing it
  • Building and running an ECT service safely and with quality, by someone who trains teams nationwide
On the table · Dr. Márcia Kauer-Sant'Anna

Demystifying the use of clozapine

The reference antipsychotic for refractory cases, used far below what the evidence supports.

“When should clinicians consider clozapine?”

Márcia Kauer-Sant'Anna, on The Psychiatry Letter podcast
  • When to indicate: the refractory patient who may be waiting for clozapine
  • Dosing: what changes when working with lower doses, and the monitoring barriers that scare prescribers
On the table · Dr. Nassir Ghaemi

Lithium: the safest and most effective of psychotropics

The most effective intervention in mood disorders and one of the least prescribed.

“If you can't or won't use lithium, you should get out of the business of treating bipolar illness.”

Frederick Goodwin, former NIMH director and Dr. Nassir Ghaemi's mentor. And Dr. Ghaemi goes further: “if you can't or won't use lithium, then you can't treat psychiatric illness well in general, including outside bipolar illness”
  • Dosing to clinical effect: what the serum level really tells you (and what it doesn't)
  • Lithium in depression, not just mania: what unbiased studies show
  • The fears that keep prescribers away: toxicity, kidneys, and what the evidence answers
Closing · Dr. Pedro and Dr. Nassir

A conversation about diagnosis in psychiatry

Two clinicians, face to face, on what comes before the prescription: recognizing the right illness.

“Treat the disease, not just the symptoms.”

The Hippocratic principle Dr. Nassir Ghaemi has defended for decades
  • The error that delays everything: bipolar depression treated for years as unipolar
  • When the diagnosis changes, the whole treatment changes: from drug choice to prognosis

Why be at this table?

Because between the comfortable protocol and real remission lies a path few master. Five moments, four experts, and an open discussion about what the evidence supports and practice has yet to reach.

Nassir Ghaemi speaking at an international congress

International guest

Dr. Nassir Ghaemi, live from the USA

  • Lecturer at Harvard · Harvard Medical School
  • Author of the clinical psychopharmacology textbook “Clinical Psychopharmacology: Principles and Practice”
  • Author of the New York Times bestseller “A First-Rate Madness”
  • Former Professor of Psychiatry at Tufts Medical Center (Boston), where he directed the Mood Disorders Program
  • World expert in bipolar disorder, depression, and clinical psychopharmacology, with over 300 published scientific articles

One of the most influential voices in world psychiatry, a speaker at congresses around the globe. Live in Brazil, for one night only.

Confirmed speakers

Who's at the table

Swipe to see all speakers →

Nassir Ghaemi

Nassir Ghaemi

Harvard · formerly Tufts Medical Center (USA)

  • Lecturer at Harvard Medical School
  • Author of “Clinical Psychopharmacology: Principles and Practice”
  • NYT bestseller “A First-Rate Madness”
  • Expert in bipolar disorder · 300+ scientific articles
Pedro do Prado Lima

Pedro do Prado Lima

Psychiatrist · PhD in Biochemistry (UFRGS)

  • Psychiatry training at CMME (Paris)
  • Leading name in clinical psychopharmacology
  • Authority on treatment-resistant depression
Márcia Kauer-Sant'Anna

Márcia Kauer-Sant'Anna

Professor of Psychiatry · UFRGS

  • President of the Brazilian Bipolar Disorder Association
  • Supervises the Bipolar Disorder clinic at HCPA
  • PhD, fellowship at the University of British Columbia (Canada)
Elias Ajub

Elias Ajub

Psychiatrist · Neuromodulation (USP/NAPEN)

  • Vice President, Hospital 22 de Outubro
  • President of CEPAB (Center for Psychiatric Studies)
  • Specialist in addiction medicine (UNIFESP)

The evening

How the symposium unfolds

6 PM ET

Opening

Reception and start of the scientific program.

Evening

International round table

Lithium, clozapine and ECT: the underused high-efficacy interventions, followed by a conversation about diagnosis in psychiatry.

After

Book launch

A special book launch following the international round table.

10 PM ET

Closing

End of the program.

Online access · pre-sale

Join the live symposium online

Follow the complete scientific program live, with real-time English captions and access to the recordings after the event.

Most speakers will present in Portuguese. Simultaneous English subtitles will be available throughout the event.

Frequently asked questions

How does online access work?

Your purchase gives you access to the live stream of the complete scientific program, from 6 PM to 10 PM Eastern Time (7 PM to 11 PM Brasília time). Access instructions will be sent to registered attendees before the event.

Will English captions be available?

Yes. Real-time English captions will be available throughout the event, since most speakers will present in Portuguese.

Are the event recordings included?

Yes. Your online purchase includes the event recordings, and you can keep access to them after the live symposium.

What time does the symposium begin?

The live program runs from 6 PM to 10 PM Eastern Time (7 PM to 11 PM Brasília time) on October 29, 2026.

Who is the symposium for?

The symposium is designed for physicians, psychiatrists, residents, and mental-health professionals interested in evidence-based clinical psychopharmacology.

I have another question. Who should I contact?

Email our team at info@psychiatryletter.com. We reply quickly.

Email info@psychiatryletter.com

October 29. One night. The great names of clinical psychiatry.

View online access